Summary Na+/K+-ATPase related strophanthidin sensitive 3-O-methylfluorescein-phosphatase activity, [3H]ouabain binding and expression of Na+/K § ATPase subunit isoforms were measured in the left ventricle of the heart of normal and streptozotocindiabetic rats with and without insulin treatment. Compared to control animals, the enzyme activity was 0.75 + 0.09 and 0.62 + 0.06 times lower in rats diabetic for 2 and for 4 weeks, respectively. This was associated with a proportional decrease of the [3H]ouabain binding sites. Immunoblots indicated a 0.76 + 0.08 and 0.61 + 0.08-fold decrease of alpha1, a 0.68 + 0.09 and 0.41 + 0.04-fold decrease of alpha 2 subunit in 2-and 4-week diabetic rats, respectively relative to controls. Beta1 subunit decreased proportionally 0.71 + 0.07 and 0.38 + 0.06-fold, and beta 2 decreased 0.75 + 0.08 and 0.31 + 0.06-fold, respectively. Northern blot analysis revealed a significant reduction in mRNA level of Na+/K+-ATPase subunit isoforms after 2 and 4 weeks of diabetes (for alpha I 66.2 + 8.2 and 55.9 + 7.8 % of controls for alpha 2 91.7 _+ 12.1 and 41.1 + 7.1% of controls and for beta subunit 93.4 + 11.1 and 49.8 + 6.8 % of controls, respectively). Although, mRNA levels of isoform reverted to even higher levels than the control values after insulin treatment, insulin caused only a partial recovery of enzyme activity, [3H]ouabain binding capacity and protein expression. We have obtained evidence that in cardiac left ventricle there are more than one type of Na+/K+-ATPase alpha and beta subunit isoforms which are affected in diabetes and by insulin treatment. The time course of diabetes induced changes and the degree of involvement suggest that the Na+/K+-ATPase isoforms are altered individually. [Diabetologia (1997[Diabetologia ( ) 40: 1255[Diabetologia ( -1262 
4 weeks diabetic rats; D2R2, 2 weeks diabetic + 2 weeks insulin-treated diabetic rats; Na+/K+-ATPase, Na + and K+-dependent ATPase; OMFP, 3-O-methylfluorescein-phosphatase; SDS, sodium dodecylsulphate. diabetes [2, 3] . The subcellular defects are suggested to be caused, at least partially, by dysfunction of Na+/K+-ATPase [4, 5] . Na+/K+-ATPase consists of catalytic alpha and glycosylated beta subunits. Three isoforms of the alpha subunit have been identified, differing in molecular weight, cation-, ATP-and ouabain-binding affinities [6] . The genes of the subunit isoforms are located at different chromosomes and are expressed in a cell-and development-specific manner [7, 8] . The beta subunit contributes to the translocation of the newly synthetized alpha subunit and also protects it from degradation [9] . Three isoforms of the beta subunit have also been described [10] . Although significance of the tissue-and cell-specific distribution of the subunit isoforms is not known, evidence is accumulating that alpha subunit isoforms may be differentially regulated by physiological and pathological stimuli [11, 12] .
Recently, it has also been demonstrated that in the heart, streptozotocin-induced diabetes caused a conspicuous reduction in enzyme activity with a marked decrease of alpha 2 [13] . In an earlier study, Fawzi and McNeill [14] reported a decrease of both low and high affinity ouabain binding sites in left ventricle obtained from chronically diabetic rats. The aims of this study were to examine the Na+/K+-ATPase activity and the Pi facilitated [3H]ouabain binding, as well as isoenzyme composition and amount of transcript coding for the Na+/K+-ATPase subunits in left ventricles of hearts from normal and diabetic rats with and without insulin treatment.
Materials and methods
Animals. Six-week-old, male Sprague Dawley (Lati, G6d6116, Hungary) rats weighing between 190-260 g were randomly assigned to four groups. C, age matched controls; D2, non-treated diabetes for 2 weeks; D4, non-treated diabetes for 4 weeks; D2Rz, diabetic for 2 weeks followed by insulin treatment for another 2 weeks. Rats were made diabetic with a single injection of streptozotocin (Sigma-Aldrich, Budapest, Hungary), buffered with 0.1 mol/1 citrate (pH 4.2) at a dosage of 65 mg/ kg body weight via the femoral vein as described previously [15] . After hyperglycaemia and glucosuria were detected diabetes was verified 24 h later (Glucose Kit; Boehringer, Mannheim, Germany). All animals were maintained on normal rat chow and water ad libitum. The diabetic and age-matched control animals (citrate buffer injected) were killed 2 and 4 weeks after the injection (groups: D2, D4). In insulin replacement studies Ultralente insulin (Novo, Copenhagen, Denmark) was administered subcutaneously, daily, for a 2-week period to the 2-week diabetic rats (groups: D2R2). The individual mean daily dosage of Ultralente insulin was 6.4 IU (between 4.1-8.5 IU). All the animals were killed in anaesthesia by decapitation and the trunk blood was collected to determine blood glucose level. The hearts were immediately removed and rapidly frozen in liquid nitrogen for subsequent RNA extraction and preparation of membrane fractions.
Subcellular fractionation.
Frozen pieces of heart left ventricle (500 mg) were homogenized in 5 ml of 0.25 mol/1 sucrose 10 mmol/1 Tris/HC1, pH 7.4 containing 2 mmol/1 phenylmethylsulphonyl fluoride (PMSF), 1 ~tg/ml aprotinin by a homogenizer (Janke and Kungel, Staufen, Germany) for 20 s at half maximal speed [16] . The homogenate was centrifuged at 2500 • g for 10 min and the pellet was discarded. The supematant was then centrifuged at 100000 • g for 60 min in a Centrikon TFT 70.38 rotor (Kontron, Zurich, Switzerland). The pellet containing plasma membrane and intracellular membranes (microsome) was finally suspended in homogenizing medium and stored at -80 ~ Protein content was assayed by the method of Bradford [17] using ovalbumin as a standard,
[~H]ouabain binding.
[3H]ouabain binding was performed as described earlier with minor modifications [18] . Microsomal fractions (20--100 ~tg protein) were incubated for 2 h at 37 ~ in 1 ml medium containing 3 mmol/1 MgCI2, 3 mmol/l imidazole/PO4, pH 7.25, [3H]ouabain 1.22 Tbq/mmol, (Amersham, Buckinghamshire, UK) and unlabelled ouabain in final concentrations of 2 • 10-8-5 • 10 -4 mol/1 (specific activity: 500-15 000 cpm/pmol). The dissociation constants (Kd) were calculated according to the methods of Scatchard using a computer program ENZFITTER (version 1.05 EGA single ligand two binding sites model; Elsevier-Biosoft, Cambridge, UK) [19] .
Enzyme assay. Na+/K+-ATPase activity was assayed in microsomal fractions by measuring the strophanthidin sensitive K+-dependent 3-O-methylfluorescein-phosphatase activity [20] . Protein was preincubated with 0.1% Na-deoxycholate pH 7.4 for 30 min at 24~ The activity was determined in the presence of 19.5~tmol/1 3-O-methylfluoresceinphosphate, 4 mmol/1 MgC12, 1 mmol/1 EDTA, 80 mmol/1 Tris/HCl, pH 7.6, 10 mmol/1 KC1 and 100 ~tg protein with and without 5 mmol/1 strophanthidin. By using a fluorescence spectrofluorimeter (F-4500; Hitachi, Tokyo, Japan) the formation of 3-O-methylfluorescein was monitored by measuring its fluorescence. The experimental data were fitted using ENZFITTER (Biosoft) [21] . 5'-nucleotidase activity was performed as described in detail earlier [22] .
Western Blot. SDS-PAGE was performed according to the method of Laemmli [23] with a BioRad Miniprotean II (Hercules, Calif., USA) system. Samples (5-50 ~g) were solubilized in a buffer of 0.125 mol/1 Tris/HC1, pH 6.7, containing 4.0 % SDS, 1 mmol/1 EDTA, 15 % glycerol, 0.1 mol/1 dithiotreitol, and 0.01% bromophenol blue. The samples were loaded on a discontinuous polyacrylamide gel [22] . The proteins were then transferred onto nitrocellulose sheets at 23 ~ for 15 min at 250 mA followed by 45 min at 350 mA. The nitrocellulose was fixed for 1 h in a blot solution containing 5 % bovine serum albumin, 0.5 % Tween 20, 150 mmol/1 NaC1, 20 mmol/1 Tris/HC1, pH 7.5 solution followed by 60 min (23~ incubation with polyclonal antibodies of the Na+/K+-ATPase subunit isoforms (UBI, Lake Placid, N.Y., USA), diluted to 1:2000. Blots were washed and then incubated by peroxidase conjugated goat anti-rabbit secondary antibody (DAKO, Glostrup, Denmark) diluted to 1 : 4000 for 30 min at 23 ~ The blots were washed and developed with the enhanced chemoluminescence Western blotting detection reagent (Amersham). The film negatives were analysed by laser densitometry (Pharmacia, Uppsala, Sweden).
Northern blot analysis. RNA was prepared from the pooled samples [24] . Northern blot analysis was performed as described [25] . Twenty ~tg of RNA was analysed by electrophoresis on denaturing 1.2 % agarose-formaldehyde gel and blotted onto Amersham Hybond-N nylon filters by capillary transfer. RNA blots were fixed and cross-linked by ultra-violet irradiation. After prehybridization the samples were hybridized to probes labelled with alpha [32p]dCTP (specific activity: 110Tbq/mmol) [26] . The Na+/K+-ATPase isoform specific probes were a generous gift of Dr. J. B. Lingrel (University of Cincinnati College of Medicine, USA). In hybridization reactions approximately 9-10 x 10 6 cpm of labelled probe and 200 Ixg/ml chicken blood DNA was added to the prehybridization solution. The autoradiographs were obtained by exposing the filters to Medifort RP 90 X-ray films (Forte, V~ic, Hungary) using an intensifying screen at -80~ for 24-96 h. The films were densitometrically analysed and the area of each hybridization band was related to the area of the corresponding ethidium bromide stained 18S ribosomal band. All the other materials were purchased by Sigma-Aldrich.
Statistical analysis. The results are expressed as a percentage of the controls and are presented as means + SEM. Unpaired Table 1 . Body, heart weight and blood glucose levels in control (C), streptozotocin-diabetic tocin-diabetic (DzR2) rats 1257 (D2, D4) and insulin-treated streptozo-
Body weight (g) initial 220. Values are means + SEM of 8-9 experiments, n = number of experimental animals, a p < 0.05 for differences between agematched control and streptozotocin-diabetic or insulin-treated streptozotocin-diabetic rats. b p < 0.05 for differences between streptozotocin-diabetic (D 2 and D4) and insulin-treated streptozotocin-diabetic (D2R2) rats Values are means + SEM of 8-9 experiments, n = number of animals. Activity of each enzyme investigated was not different in the 2-and 4-week control groups, therefore C denotes all the age-matched control groups. The strophanthidin sensitive 3-0-methylfluorescein-phosphatase (AOMFP) represents Na+/K +-ATPase activity while the strophanthidin insensitive 3-O-methylfluorescein-phosphatase (OMFP + strophanthidine) represents the basal ATPase activity a p < 0.05 for differences between control and streptozotocin-diabetic (D2, D4). b p < 0.05 for: differences between control and insulin-treated streptozotocin-diabetic (D2R2) rats. C p < 0.05 for differerlces between 2-week diabetic and insulin-treated diabetic (D2R2). d p < 0.05 for differences between 4-week diabetic and insulin-treated diabetic (D2R2) Student's t-test was used to compare the controls and diabetic groups. A Bonferroni correction for multiple comparisons was used to evaluate the significance of the data. Student's ttest was used throughout this study to compare the differences in various parameters examined. The difference between the means was considered to be significant ifp was less than 0.05.
Results
Body and heart weight. The body and the heart weights of streptozotocin-diabetic rats were significantly lower than those of the age-matched non-diabetic controls. Table 1 shows that after 2 and 4 weeks of diabetes the mean final body weight had decreased by an average of 21.1 + 3.7 % and 30.08 + 4.1%, while that of age-matched non-diabetic controls had increased by 8.8 + 0.93 % and 17.4 _+ 2.41%, respectively (p < 0.05). The heart weight of diabetic animals also decreased, but heart weight to body weight ratios did not change. The treatment of diabetic animals with insulin for 2 weeks was found to decrease the blood glucose level with a concomitant enhancement of body and heart weight ( Table 1) .
Enzyme activities of heart microsomes. Strophanthidin sensitive 3-O-methylfluorescein-phosphatase activity decreased in diabetic heart left ventricle 0.75 + 0.09-fold within 2 weeks of the onset of diabetes and decreased further 0.62+0.06-fold during 4 weeks of diabetes. Insulin treatment partially restored strophanthidin sensitive 3-O-methylfluorescein-phosphatase activity ( Table 2 ). The strophanthidin concentration producing half maximal inhibition was not significantly different among the groups tested: it was 0.81 + 0.06 ~tmol/1 for controls, 0.78+0.032 ~tmol/1 for 4-week diabetic rats and 0.83 + 0.032 ~tmol/1 for diabetic insulin-treated animals (D2R2). The strophanthidin independent 3-0-methylfluorescein-phosphatase and 5'-nucleotidase activity was found to be equal in all groups examined. The activities of all the examined enzymes were the same in the 2-and 4-week control groups, therefore control (C) represents all the age-matched controls in the presentation of the results.
[3H]ouabain binding capacity. The Scatchard type plot gives two populations of binding sites with Table 3 also shows the contribution of the isoenzymes in terms of low (alpha1) and high affinity ouabain binding sites (alpha2). In 2-week diabetic animals the reduction in ouabain binding was about 20 % in the case of both types of ouabain binding sites. However, in 4-week diabetic animals the reduction was more pronounced in the number of high affinity ouabain binding sites (48.26+6.4%) than in the low affinity sites (30.5 + 4.4 %). The maximal [3H]ouabain binding capacity was partially reversed by insulin treatment (D2R2) compared to the controls (C), yet it was higher than the 4-week diabetic values. The turnover rate of the enzyme (strophanthidin sensitive 3-O-methylfluorescein-phosphatase activity per maximal [3H]ouabain binding) did not significantly differ in the groups examined (Table 3) .
Western blot analysis of heart microsomes. In heart left ventricle two alpha and beta isoforms could be detected in all the groups examined. The alpha I and alpha 2 protein levels indicated that alpha I represented the majority (> 70 %) of Na+/K+-ATPase in the control left ventricles. No alpha 3 specific band was detected. The beta a and beta2 protein levels suggested that beta a is the predominant isoform of beta (> 60%). A representative immunoblot of control and diabetic heart left ventricles is shown in Figure 1 . The control level of each species is designated as 100 % in Figure 2 . The quantity of the alpha 1 isoform decreased significantly after 2 weeks of diabetes to 76.2 + 8.2 % of the controls, alpha 2 isof0rm decreased to 78.1 + 8.7 % of the controls. Also the level of beta1 was 71.18 + 6.91% and beta 2 75.1 + 6.9 % of the controls in 2-week diabetic heart left ventricle. Moreover in 4-week diabetes alpha a isoform decreased to 61.3+7.8% and alpha 2 isoform decreased to 41.1 + 4.1% of the controls. The level of beta a subunit decreased to 38.12 + 5.75 % and beta 2 subunit decreased to 31.42 + 5.75 % of the controls during 4 weeks of diabetes. Two weeks' insulin treatment of the 2-week diabetic animals (DzR2) did not completely restore the original isoform pattern. The relative amount of alpha~ isoform in diabetic insulin-treated animals was lower compared to the controls (86.8 + 7.9 %), but it was 1.14 + 0.2 times higher than the 2-week diabetic and it was 1.42 _+ 0.15 times higher than the 4-week diabetic values. The amount of alpha 2 was 1.12 + 0.1 times higher than the 2-week diabetic and 2.19 + 0.3 times higher than 4-week diabetic values. Insulin treatment increased the beta I level to 105.1 + 12.7 % and the beta 2 level to 127.3 _+ 11.7 % of control values, respectively. This was a 1.47 + 0.2-fold and 1.7 + 0.2-fold increase compared to the 2-week diabetic values and 2.7+0.32 and 4.1 +0.5 times higher than 4-week diabetic values, respectively.
Northern blot analysis. RNA samples were subjected to Northern blot analysis to examine the integrity of the RNA preparation and the amount of the mRNA between controls and streptozotocin-diabetic (D2, D4). 9 *p < 0.05 differences between control and insulin-treated streptozotocin-diabetic (D2R2) rats. ***p <0.05 differences between 2-week diabetic (D2) and insulin-treated diabetic (D2R2) rats. + p < 0.05 differences between 4-week diabetic (D4) and insulin-treated diabetic (DaR2) rats The control level of each species is designated as 100%. * p < 0.05 for differences between controls (C) and streptozotocin-diabetic (D2, D4). ** P < 0.05 for differences between control and insulin-treated streptozotocin-diabetic (DzR2) rats. *** p < 0.05 differences between 2-week diabetic and insulintreated diabetic (D2R2) rats. + p < 0.05 differences between 4-week diabetic and insulin-treated diabetic (D2R2) rats level of different Na+/K+-ATPase isoforms. The alpha I p r o b e hybridized to a single 3.7 kb band. Two bands of m R N A w e r e detected by hybridization with alpha 2 c D N A clone at 3.4"and 5.3 kb, respectively. No significant hybridization was found in the case of alpha 3 c D N A clone either in the control or in the diabetic heart samples. The beta subunit p r o b e which contained both beta I and beta2 isoforms c D N A hybridized to two major species (Fig. 3) . The m R N A of beta actin is also shown as control. The alpha1 and alpha 2 m R N A levels indicated that alpha~ r e p r e s e n t e d the majority (> 75 %) of Na+/K+-ATPase transcript in the left ventricle of the control rat hearts. The relative levels of alpha and beta subunit m R N A s are shown in Figure 4 . The results are expressed as the p e r c e n t a g e relative to the m R N A level m e a s u r e d in the age-matched, control animals. N o r t h e r n blot analysis of the total R N A samples revealed that m R N A levels of alpha 1 subunit significantly decreased to 66.2 + 8.2 % of the controls during the first 2 weeks of diabetes and was 55.9 + 6.9 % of the controis in 4 weeks of diabetes. The alpha 2 m R N A did not significantly change in the first 2 weeks of the diabetic state (91.7 + 12.1% of the controls, p > 0.5), but decreased to 41.1 + 7 . 1 % of the controls in the 4-week diabetic animals. The m R N A level of the beta subunit was 93.4 + 11.1% in 2-week diabetic and decreased to 49.8 + 6.32 % of the controls in the 4-week diabetic animals. The m R N A level of beta actin did not change significantly in diabetes. The insulin t r e a t m e n t increased the a m o u n t of alpha 1 over the control (134.7 + 13.6 %) and it was 2.0 + 0.3 and 2.4 + 0.25 times higher than the 2-and 4-week diabetic left ventricle. Alpha 2 m R N A level was 128.7 + 14.1% of the controls. It was 1.4 + 0.2 and 3.1 + 0.4 times higher than the 2-and 4-week diabetic left ventricle. The level of the beta subunit mRNA was not significantly changed compared to the 2 weeks' diabetic heart; however, it exceeded the level of the 4-week diabetic rats by 1.9 + 0.25-fold.
Discussion
In this study we examined diabetes-induced alterations in Na+/K+-ATPase activity, in ouabain binding capacity, isoenzyme composition and mRNA expression in the early phase of diabetes. We also assessed the reversibility of the diabetes-induced abnormalities by insulin administration. It was reported that insulin stimulated the sarcolemmal Na+-pump activity or the sarcolemmal ATPase activity in cardiac muscle [27] . Therefore, the chronic defect of circulating insulin must depress the enzyme activity of cardiac sarcolemma. Indeed, an increased intracellular Na + concentration was also observed in diabetic heart muscle [28] . As shown earlier, the Na+/K+-ATPase activity was reduced in the diabetic heart [29] . Similar results were obtained in the present study. Moreover, we showed that the enzyme activity decreased progressively during diabetes. The decrease involved both the low affinity and the high affinity components of ouabain binding sites similar to that published earlier [14] . Nevertheless the time course of the alteration of the individual components of ouabain binding sites differ. The low affinity binding sites (referring to alpha~ isoform of Na+/K+-ATPase) decreased significantly during the first 2 weeks of diabetes and remained near to this level. But the high affinity sites (referring to alpha 2 isoform of Na+/K +-ATPase) decreased continuously. The fact that both isoenzymes are affected in diabetic heart alterations is contrary to earlier dogma that it is usually the alpha 2 isoenzyme which is responsive to diabetes [30, 31] . While this manuscript was in preparation in agreement with our data, Gerbi et al. [32] published that the activity of the low affinity isoenzyme is decreased in diabetes [32] . Since we found that the turnover rate of Na+/K+-ATPase (ATPase activity/ [3H]ouabain binding) does not change significantly during diabetes and insulin treatment, there is a possibility that the decrease in ATPase activity arises from the decrease in the amount of ATPase molecule [33] , rather than inactivation or modification of the enzyme as suggested by others [32] . The results of our Western blot analysis of the samples supported the above assumption. Both isoforms of catalytic subunit (alpha 1 and alpha2) decrease in 2 and 4 weeks of diabetes in the left ventricle. The alpha 1 decreases mainly in the first 2 weeks of diabetes. On the other hand alpha 2 decreases continuously, similarly to the high affinity ouabain binding sites. However, contrary to our results, Gerbi et al. [32] found that alpha I isoform protein enhanced in 8 weeks of diabetes [32] . These discrepancies may be the result of the difference of the heart weight/body weight ratio in 4-and 8-week diabetic animals [34] . Similarly to the earlier report, our results show that the heart weight/body weight ratio does not change compared to controls in the first 4 weeks of experimental diabetes [34] . Yet, there is a significant enhancement in heart weight/body weight ratio in 8-week diabetes [32, 34] . In the light of the above data we can only assume that as opposed to 8 weeks' duration of diabetes, the 4-week duration of untreated experimental diabetes is not associated with cardiac hypertrophy [34] . Interestingly, it is the right ventricle which is dominant in diabetic hypertrophy [35] . Furthermore, we have to take into account that the right ventricle of the rat heart has 2.6 times more [3H]ouabain binding site density than the left ventricle [36] . The above-mentioned differences might explain the contradictions.
Another major goal of this study was to investigate the possible involvement of beta subunits in diabetic alterations. We found that the left heart ventricle contains two types of beta subunits similarly to brain and skeletal muscle [10] . The presence of mRNA of beta2 subunit in rat heart has already been reported [37] . It is also suggested that under some conditions its expression is regulated together with alpha 2 [37] . In contrast to others, we found by using rat specific polyclonal antibodies that the left ventricle contained both beta 1 and beta 2 subunits [32] . In addition, both types of beta subunit proteins decreased in diabetes. This was especially true in 4-week diabetes, where the protein level of beta subunits decreased more than that of the alpha subunits. Insulin administration reverted the beta subunit protein levels over the controls. The role of the beta subunit is still highly questionable [9] and it is also debated whether the alpha/beta ratio might modify the ATPase activity [32, 38] .
Streptozotocin-induced diabetes in rats is characterized by hyperglycaemia, a decrease in serum insulin and an increase in serum immunoreactive glucagon concentration [39] . It is also associated with the increase in serum concentrations of mineralo-and glucocorticoids [40] , with a decrease in serum concentrations of thyroid hormones [40] , an increase in serum K + and decrease in total body K + [41] . It is well documented that aldosterone alone is sufficient to induce alpha 1 and beta I gene expression in cardiomyocytes [42] . In hypokalaemia, alpha 2 isoform expression is depressed in the heart [11] . In the heart, it is mainly the alpha 2 and beta I mRNA level that is influenced by hypothyroid state [43, 44] . According to our data, in 2-week diabetes only the alpha I mRNA level decreased, as opposed to the hypothyroid state and to aldosterone effect. However, 4 weeks of diabetes altered both alphas, alpha 2 catalytic isoforms and the beta subunit at the transcription level. We cannot exclude the possibility that these changes in hormonal and ionic status may also play a role in altered expression of Na+/K+-ATPase isoforms in this model of diabetes [45, 46] . Furthermore, the diabetes induced metabolic abnormalities might also alter the ATPase functions [47] .
In agreement with our previous reports insulin enhances Na+/K+-ATPase activity [48] . The insulininduced enhancement of Na+/K+-ATPase activity is a consequence of the increase of protein and mRNA level, but the insulin effect is not isoform specific [22, 26] . It seems that in the chronic insulin deficient state the regulation of alpha 1 catalytic isoform is primarily arranged at the transcription level both in 2-and 4-week diabetes. This is suggested by the correlation among the changes of low affinity ouabain binding sites, the changes of alpha x protein and the alpha I mRNA level. The replacement of insulin results in a marked increase of mRNA and of protein level. However, the amount of alpha 2 mRNA is not significantly influenced in the first 2 weeks of the insulin-deficient state, but it is decreased by a great amount after 4 weeks of insulin deficiency. In contrast to mRNA, the protein level of alpha 2 isoform and consequently the enzyme function (high affinity binding sites) also decreased significantly in 2-week diabetes. This suggests that the regulation of alpha 2 isoform might occur at a post-transcriptional level in the early state of diabetes. However, in 4 weeks of experimental diabetes the decrease in the high affinity binding sites (alpha 2 isoform) is the result of the decrease of Na+/K +-ATP-ase isoform which itself is the consequence of the lower level of its mRNA. Insulin administration enhanced both mRNA and protein levels of the subunits. The mRNA level of alpha subunits increased at a higher rate than the beta subunits; however, in protein level the enhancement of beta subunits is more pronounced than alphas.
In conclusion, we have obtained evidence that in cardiac left ventricle there are more than one type of Na+/K+-ATPase alpha and beta subunit isoforms which are affected in diabetes and by insulin treatment. The time course of diabetes induced changes and the degree of involvement suggest that the Na+/ K+-ATPase isoforms are altered individually. Furthermore, our results also suggest that beside the changes in transcription of Na+/K+-ATPase the alterations in translation, and/or degradation of the enzyme might also influence the level and function of the enzyme. We are at present further researching the above-mentioned aspects of diabetes induced changes in Na+/K+-ATPase.
